BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26264646)

  • 1. Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.
    Zhao Y; Huo M; Xu Z; Wang Y; Huang L
    Biomaterials; 2015 Nov; 68():54-66. PubMed ID: 26264646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment.
    Huo M; Zhao Y; Satterlee AB; Wang Y; Xu Y; Huang L
    J Control Release; 2017 Jan; 245():81-94. PubMed ID: 27863995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
    Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
    J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells.
    Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY
    Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer.
    Ball MS; Bhandari R; Torres GM; Martyanov V; ElTanbouly MA; Archambault K; Whitfield ML; Liby KT; Pioli PA
    Sci Rep; 2020 Apr; 10(1):6560. PubMed ID: 32300202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Cells and CDDO-Me Attenuate Immunosuppressive Activation of Human Melanoma-Conditioned Macrophages.
    Torres GM; Yang H; Park C; Spezza PA; Khatwani N; Bhandari R; Liby KT; Pioli PA
    Front Immunol; 2022; 13():768753. PubMed ID: 35265066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.
    Nagaraj S; Youn JI; Weber H; Iclozan C; Lu L; Cotter MJ; Meyer C; Becerra CR; Fishman M; Antonia S; Sporn MB; Liby KT; Rawal B; Lee JH; Gabrilovich DI
    Clin Cancer Res; 2010 Mar; 16(6):1812-23. PubMed ID: 20215551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.
    Zou W; Chen S; Liu X; Yue P; Sporn MB; Khuri FR; Sun SY
    Cancer Biol Ther; 2007 Oct; 6(10):1614-20. PubMed ID: 18253090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
    Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
    J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells.
    Kim KB; Lotan R; Yue P; Sporn MB; Suh N; Gribble GW; Honda T; Wu GS; Hong WK; Sun SY
    Mol Cancer Ther; 2002 Jan; 1(3):177-84. PubMed ID: 12467212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model.
    Lu Y; Miao L; Wang Y; Xu Z; Zhao Y; Shen Y; Xiang G; Huang L
    Mol Ther; 2016 Feb; 24(2):364-374. PubMed ID: 26334519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma.
    Hou L; Liu Q; Shen L; Liu Y; Zhang X; Chen F; Huang L
    Theranostics; 2018; 8(14):3781-3796. PubMed ID: 30083259
    [No Abstract]   [Full Text] [Related]  

  • 13. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
    Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC
    Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma.
    Gao X; Deeb D; Liu Y; Liu P; Zhang Y; Shaw J; Gautam SC
    Int J Oncol; 2015 Dec; 47(6):2100-6. PubMed ID: 26497549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me).
    Yue P; Zhou Z; Khuri FR; Sun SY
    Cancer Biol Ther; 2006 May; 5(5):492-7. PubMed ID: 16582599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent.
    Deeb D; Gao X; Liu YB; Gautam SC
    J Exp Ther Oncol; 2012; 10(1):51-64. PubMed ID: 22946344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma by a large-scale synthetic lethal RNAi screening.
    Qin Y; Deng W; Ekmekcioglu S; Grimm EA
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):97-112. PubMed ID: 23020131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer Cells.
    Qin DJ; Tang CX; Yang L; Lei H; Wei W; Wang YY; Ma CM; Gao FH; Xu HZ; Wu YL
    PLoS One; 2015; 10(7):e0132337. PubMed ID: 26134508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
    Liby K; Risingsong R; Royce DB; Williams CR; Yore MM; Honda T; Gribble GW; Lamph WW; Vannini N; Sogno I; Albini A; Sporn MB
    Clin Cancer Res; 2008 Jul; 14(14):4556-63. PubMed ID: 18628471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells.
    Gao X; Liu Y; Deeb D; Liu P; Liu A; Arbab AS; Gautam SC
    Anticancer Res; 2013 Jan; 33(1):215-21. PubMed ID: 23267148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.